PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Mar-2021 Takeda consigue los derechos globales de Ovid Therapeutics para desarrollar y comercializar el fármaco soticlestat para el tratamiento de niños y adultos con síndrome de Dravet y síndrome de Lennox-Gastaut Businesswire
04-Mar-2021 Kyowa Kirin Responds to the National Institute for Health and Care Excellence (NICE) Decision to Not Provide People Living With Certain Rare Blood Cancers Access to POTELIGEO® (mogamulizumab) Businesswire
04-Mar-2021 UK Regulatory Announcement: Net Asset Value(s) Businesswire
04-Mar-2021 Exscientia Completes $100 million Series C Financing Round With BlackRock Funds Businesswire
04-Mar-2021 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Tricida, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Mar-2021 Oregon Bioscience Association Appoints 2021 Leadership Businesswire
04-Mar-2021 Riassunto: Takeda si assicura i diritti globali da Ovid Therapeutics per sviluppare e commercializzare soticlestat per il trattamento di bambini e adulti affetti da sindrome di Dravet e sindrome di Lennox-Gastaut Businesswire
03-Mar-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of Investors Businesswire
03-Mar-2021 INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of Investors Businesswire
03-Mar-2021 Takeda obtient les droits mondiaux d'Ovid Therapeutics pour le développement et la commercialisation de Soticlestat pour le traitement des enfants et des adultes atteints du syndrome de Dravet et du syndrome de Lennox-Gastaut Businesswire
03-Mar-2021 Axcella Announces Alison D. Schecter, M.D., as President of R&D Businesswire
03-Mar-2021 NANOBIOTIX to Present at the H.C. Wainwright Global Life Sciences Conference Businesswire
03-Mar-2021 Takeda garante os direitos globais da Ovid Therapeutics para desenvolver e comercializar o soticlestat para o tratamento de crianças e adultos com síndrome de Dravet e síndrome de Lennox-Gastaut Businesswire
03-Mar-2021 Rimini Street Announces Fiscal Fourth Quarter and Annual 2020 Financial Results Businesswire
03-Mar-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ontrak, Inc. (OTRK) on Behalf of Investors Businesswire
03-Mar-2021 Ridgeback Biotherapeutics Announces Publication of Phase 1 Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Molnupiravir in Healthy Volunteers Businesswire
03-Mar-2021 Pharmacovigilance and Drug Safety Software Markets: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software - Global Forecast to 2026 - ResearchAndMarkets.com Businesswire
03-Mar-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ormat Technologies, Inc. (ORA) on Behalf of Investors Businesswire
03-Mar-2021 SPIE and Photonics Media Prism Awards Honor Photonics Innovations Businesswire
03-Mar-2021 Celltrio and Biosero Automated Solutions Accelerate Cell Culture and Harvesting Process 2-3 Fold Businesswire